•
Sep 30, 2023

Exelixis Q3 2023 Earnings Report

Exelixis reported strong Q3 2023 financial results, driven by the CABOMETYX® commercial franchise, and provided a corporate update.

Key Takeaways

Exelixis announced strong Q3 2023 financial results with total revenues of $471.9 million, compared to $411.7 million for the comparable period in 2022. Net product revenues were $426.5 million, an increase from $366.5 million in the same period of the prior year. GAAP net income was $1.0 million, or $0.00 per share, while non-GAAP net income was $32.1 million, or $0.10 per share.

Total revenues for Q3 2023 were $471.9 million, compared to $411.7 million for the comparable period in 2022.

Net product revenues for Q3 2023 were $426.5 million, compared to $366.5 million for the comparable period in 2022.

GAAP net income for Q3 2023 was $1.0 million, or $0.00 per share, compared to $73.2 million, or $0.23 per share for the comparable period in 2022.

Non-GAAP net income for Q3 2023 was $32.1 million, or $0.10 per share, compared to $102.0 million, or $0.32 per share for the comparable period in 2022.

Total Revenue
$472M
Previous year: $412M
+14.6%
EPS
$0.1
Previous year: $0.31
-67.7%
R&D Expenses
$333M
Previous year: $199M
+67.3%
SG&A Expenses
$138M
Previous year: $115M
+20.1%
Tax Expense
$4.8M
Previous year: $18.8M
-74.5%
Gross Profit
$453M
Previous year: $396M
+14.3%
Cash and Equivalents
$1.1B
Previous year: $675M
+63.4%
Free Cash Flow
$108M
Previous year: $102M
+5.8%
Total Assets
$2.98B
Previous year: $2.96B
+0.5%

Exelixis

Exelixis

Exelixis Revenue by Segment

Forward Guidance

Exelixis is providing the following updated financial guidance for fiscal year 2023:

Positive Outlook

  • Total revenues $1.825 billion - $1.850 billion
  • Net product revenues $1.625 billion - $1.650 billion
  • Cost of goods sold4.0% - 5.0% of net product revenues
  • Research and development expenses (1)$1.050 billion - $1.075 billion
  • Selling, general and administrative expenses (2)$525 million - $550 million

Challenges Ahead

  • Effective tax rate20% - 22%
  • Total revenues $1.825 billion - $1.850 billion
  • Net product revenues $1.625 billion - $1.650 billion
  • Research and development expenses (1) $1.050 billion - $1.075 billion
  • Selling, general and administrative expenses (2) $525 million - $550 million

Revenue & Expenses

Visualization of income flow from segment revenue to net income